The Current Therapeutic Landscape for CV Risk Reduction in Patients with Hypercholesterolemia: New Developments in LDL-Focused CV Risk Reduction in High Risk Populations–From Mechanism to Management - Deepak L. Bhatt, MD, MPH, FACC, FAHA, FSCAI, FESC - Program Co-Chair